Social Clips Last Week’s Top-3 Most Read Posts On Scleroderma Last Week’s Top-3 Most Read Posts On Scleroderma by admin | November 23, 2015 Share this article: Share article via email Copy article link Read the Articles Here: Genkyotex’s Systemic Sclerosis Therapy Granted Orphan Drug Designation Mycophenolate Mofitil Identified As Promising Scleroderma-Related Interstitial Lung Disease Treatment Systemic Sclerosis Patients’ Intestinal Microbiome Found To Be Enriched by Inflammatory Bacteria Print This Page Tags Genkyotex, Intestinal Microbiome, mycophenolate mofitil
April 1, 2025 News by Andrea Lobo, PhD Study of CAR T-cell therapy rese-cel in scleroderma enrolling in US
March 25, 2025 News by Andrea Lobo, PhD Ofev effectiveness, safety seen over 3-year SENSCIS extension trial
March 18, 2025 News by Margarida Maia, PhD Phase 1 trial of CAR T-cell therapy likely to open soon to SSc patients
